Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2020-11-26 2021-04-15 128922
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2021-06-11 2021-08-03 140767
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2023-02-16 2023-04-21 185033
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2023-05-06 2023-06-16 191892
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-18 28534
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-08-07 121322
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-18 2021-01-20 131809
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-12 2024-03-22 215973
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-05-24 225779
APO-ALLOPURINOL 300MG TABLET Resolved 2019-01-30 2019-02-13 74014
APO-ALLOPURINOL 100MG TABLET Resolved 2020-02-13 2020-04-23 105988
APO-ALLOPURINOL 300MG TABLET Resolved 2020-07-23 2021-05-17 120971
APO-ALLOPURINOL 200MG TABLET Resolved 2020-08-19 2021-05-17 122465

Showing 201 to 220 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-CARVEDILOL 25MG TABLET Discontinued 2024-01-26 2024-01-27 217504
APO-CEFPROZIL 500MG TABLET Discontinued 2018-04-04 2018-10-05 44945
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CEPHALEX 250MG TABLET Discontinued 2018-09-07 2019-02-21 60370
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-CICLESONIDE 50MCG SPRAY, METERED DOSE Discontinued 2018-12-20 2018-12-21 70250
APO-CILAZAPRIL 1MG TABLET To be discontinued 2018-09-07 2018-12-28 60373
APO-CIPROFLOX 250MG TABLET Discontinued 2018-09-07 2018-09-15 60379
APO-CIPROFLOX 500MG TABLET Discontinued 2018-09-07 2018-09-15 60382
APO-CIPROFLOX 500MG TABLET Discontinued 2018-09-07 2018-09-15 60385
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-CIPROFLOX Discontinued 2019-06-12 2019-06-12 86547
APO-CITALOPRAM 20MG TABLET Discontinued 2018-09-07 2019-02-13 60393
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 101 to 120 of 356